Skip to content
10-Q

Quarterly Report

BioTelemetry, Inc.

0001574774-20-000106

← back to feed
Filed
Oct 29, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Oct 23, 2020 34.26M sh
Shares Diluted Q3 2020 · Sep 30, 2020 36.62M sh
Shares Diluted Q3 2020 · Sep 30, 2020 36.63M sh
Shares Diluted Q3 2020 · Sep 30, 2019 36.27M sh
Shares Diluted Q3 2020 · Sep 30, 2019 36.45M sh
Capex Q3 2020 · Sep 30, 2020 $27.88M
Capex Q3 2020 · Sep 30, 2019 $23.69M
Operating Cash Flow Q3 2020 · Sep 30, 2020 $91.43M
Operating Cash Flow Q3 2020 · Sep 30, 2019 $52.6M
Long Term Debt Q3 2020 · Sep 30, 2020 $157.88M
Long Term Debt Q3 2020 · Dec 31, 2019 $190.82M
Short Term Debt Q3 2020 · Sep 30, 2020 $0
Short Term Debt Q3 2020 · Dec 31, 2019 $3.84M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $90.23M
Cash And Equivalents Q3 2020 · Dec 31, 2019 $68.61M
Cash And Equivalents Q3 2020 · Sep 30, 2019 $61.57M
Cash And Equivalents Q3 2020 · Dec 31, 2018 $80.89M
Stockholders Equity Q3 2020 · Sep 30, 2020 $396.38M
Stockholders Equity Q3 2020 · Dec 31, 2019 $366.92M
Current Liabilities Q3 2020 · Sep 30, 2020 $68.01M
Current Liabilities Q3 2020 · Dec 31, 2019 $55.75M
Total Liabilities Q3 2020 · Sep 30, 2020 $340.71M
Total Liabilities Q3 2020 · Dec 31, 2019 $318.8M
Current Assets Q3 2020 · Sep 30, 2020 $190.38M
Current Assets Q3 2020 · Dec 31, 2019 $168.33M
Total Assets Q3 2020 · Sep 30, 2020 $737.1M
Total Assets Q3 2020 · Dec 31, 2019 $685.72M
Eps Diluted Q3 2020 · Sep 30, 2020 $0.18
Eps Diluted Q3 2020 · Sep 30, 2020 $0.44
Eps Diluted Q3 2020 · Sep 30, 2019 $0.23
Eps Diluted Q3 2020 · Sep 30, 2019 $0.78
Eps Basic Q3 2020 · Sep 30, 2020 $0.20
Eps Basic Q3 2020 · Sep 30, 2020 $0.47
Eps Basic Q3 2020 · Sep 30, 2019 $0.24
Eps Basic Q3 2020 · Sep 30, 2019 $0.83
Sga Expense Q3 2020 · Sep 30, 2020 $32.76M
Sga Expense Q3 2020 · Sep 30, 2020 $95.74M
Sga Expense Q3 2020 · Sep 30, 2019 $29.65M
Sga Expense Q3 2020 · Sep 30, 2019 $87.85M
Rd Expense Q3 2020 · Sep 30, 2020 $3.04M
Rd Expense Q3 2020 · Sep 30, 2020 $9.31M
Rd Expense Q3 2020 · Sep 30, 2019 $3.66M
Rd Expense Q3 2020 · Sep 30, 2019 $10.53M
Operating Income Q3 2020 · Sep 30, 2020 $11.89M
Operating Income Q3 2020 · Sep 30, 2020 $31.44M
Operating Income Q3 2020 · Sep 30, 2019 $15M
Operating Income Q3 2020 · Sep 30, 2019 $43.89M
Gross Profit Q3 2020 · Sep 30, 2020 $68.99M
Gross Profit Q3 2020 · Sep 30, 2020 $201.02M
Gross Profit Q3 2020 · Sep 30, 2019 $69.34M
Gross Profit Q3 2020 · Sep 30, 2019 $204.36M
Cost Of Revenue Q3 2020 · Sep 30, 2020 $45.67M
Cost Of Revenue Q3 2020 · Sep 30, 2020 $125.77M
Cost Of Revenue Q3 2020 · Sep 30, 2019 $41.95M
Cost Of Revenue Q3 2020 · Sep 30, 2019 $122.72M
Revenue Q3 2020 · Sep 30, 2020 $114.66M
Revenue Q3 2020 · Sep 30, 2020 $317.09M
Revenue Q3 2020 · Sep 30, 2019 $111.29M
Revenue Q3 2020 · Sep 30, 2019 $327.07M